Run critical care trials with speed, precision and confidence
Deliver predictable execution in high-acuity ICU environments across biopharma, medical device and diagnostics programmes
Critical care trials demand real-time decision-making, continuous execution and alignment with complex ICU workflows. ICON enables sponsors to run studies that are not only scientifically rigorous, but operationally executable.
Additionally, ICON has experience in trauma and surgical critical care, multilple organ dysfunction syndrome (MODS) support and other specialised ICU populations.
Advancing research in the most complex clinical environments
Critical care trials span conditions such as sepsis, ARDS, acute kidney injury and severe infections.
ICON supports biopharma, medical device and diagnostics sponsors across global programmes, delivering specialised operational and scientific expertise to drive reliable recruitment, consistent execution and high-quality outcomes in complex critical care studies, including ICUs and comparable monitored environments.
Our experience in critical care in the past five years:
-
15+
critical care studies -
2,200+
patients in critical care units -
750+
global sites
Why critical care trials are uniquely challenging
Critical care trials operate in fundamentally different conditions than traditional clinical research where time, variability and clinical priorities redefine how studies must be delivered.
Many critical care trials do not fail due to lack of eligible patients but because those patients are not identified and enrolled within the narrow clinical window in which intervention is possible.
These challenges are driven by a combination of scientific complexity and real-world execution constraints:
A purpose-built operating model for critical care trials
Success in critical care trials is determined by execution capability and real-time operational readiness, not protocol design alone.
ICON delivers a specialised model aligned to ICU environments, enabling real-time execution rather than retrospective management.
Unlike traditional CRO models, ICON’s approach is designed specifically for continuous ICU environments where timing, workflow integration and real-time execution determine success.
- Clinical study design and execution A flexible approach to improve cycle times, constrain costs, and reduce risks through clinical trial planning, management, execution and analysis
- Site & Patient Solutions Patient centric clinical trial services increasing recruitment and retention
- Regulatory and QA support Strategic consulting and operational support in a complex environment
- Commercialisation and outcomes Integrated solutions to accelerate market access and drive product adoption
- Strategic resourcing Customised FSP models to drive operational efficiencies and accelerate clinical development
- Cardiac Safety Solutions End-to-end cardiac safety support for your clinical trials
- Medical Device & Diagnostics Research Accelerating the development of devices and diagnostics that save lives and improve quality of life.
Clinical study design and execution
A flexible approach to improve cycle times, constrain costs, and reduce risks through clinical trial planning, management, execution and analysis
Site & Patient Solutions
Patient centric clinical trial services increasing recruitment and retention
Regulatory and QA support
Strategic consulting and operational support in a complex environment
Commercialisation and outcomes
Integrated solutions to accelerate market access and drive product adoption
Strategic resourcing
Customised FSP models to drive operational efficiencies and accelerate clinical development
Cardiac Safety Solutions
End-to-end cardiac safety support for your clinical trials
Medical Device & Diagnostics Research
Accelerating the development of devices and diagnostics that save lives and improve quality of life.
Delivering measurable impact in critical care trials
ICON helps sponsors translate complex critical care studies into predictable, high-quality outcomes:
- Faster time to first patient in and improved enrolment performance
- Greater predictability across high-risk, heterogeneous trials
- Fewer protocol deviations and more consistent site execution
- Higher confidence in data to support critical decisions
- Accelerated progression of key programmes
Designing trials that work in practice
Improving outcomes in critical care requires more than strong scientific design—it demands an approach aligned to how trials are delivered in real-world ICU environments.
Success depends on bridging the gap between study design and execution, ensuring that protocols can be implemented consistently within fast-paced, high-acuity clinical settings.
Key considerations are listed below. Together, these principles help ensure that scientific ambition is matched by operational feasibility, improving the likelihood of successful outcomes in critical care studies.
Critical care trial considerations:
Together, these principles help ensure that scientific ambition is matched by operational feasibility, improving the likelihood of successful outcomes in critical care studies.
Reducing variability through patient stratification
Using biomarkers and enrichment strategies to better define populations
Enabling real-time patient identification
Embedding screening into clinical workflows to capture narrow enrolment windows
Designing protocols for bedside feasibility
Ensuring procedures can be delivered within ICU care settings
Building flexibility into trial design
Applying adaptive approaches to respond to emerging data
Focusing on critical data through smarter monitoring
Using targeted strategies to manage complexity and variability
Navigating the complexities and nuances of critical care clinical trials
